Global Continuous Glucose Monitoring (CGM) Market Growth 2024-2030

Publication ID:

LPI03242793

Publication Date:

March 5, 2024

Pages:

100

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Continuous Glucose Monitoring (CGM) market size was valued at US$ 4511.7 million in 2023. With growing demand in downstream market, the Continuous Glucose Monitoring (CGM) is forecast to a readjusted size of US$ 5872.7 million by 2030 with a CAGR of 3.8% during review period.
The research report highlights the growth potential of the global Continuous Glucose Monitoring (CGM) market. Continuous Glucose Monitoring (CGM) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Continuous Glucose Monitoring (CGM). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Continuous Glucose Monitoring (CGM) market.
A continuous glucose monitoring (CGM) system may help in these cases. The system consists of a small disposable sensor inserted into the skin, a transmitter connected to the sensor by a sensor mount wirelessly transmits results to a receiver and displays results.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Continuous Glucose Monitoring (CGM) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Continuous Glucose Monitoring (CGM) market. It may include historical data, market segmentation by Type (e.g., Transmitters, Sensors), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Continuous Glucose Monitoring (CGM) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Continuous Glucose Monitoring (CGM) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Continuous Glucose Monitoring (CGM) industry. This include advancements in Continuous Glucose Monitoring (CGM) technology, Continuous Glucose Monitoring (CGM) new entrants, Continuous Glucose Monitoring (CGM) new investment, and other innovations that are shaping the future of Continuous Glucose Monitoring (CGM).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Continuous Glucose Monitoring (CGM) market. It includes factors influencing customer ' purchasing decisions, preferences for Continuous Glucose Monitoring (CGM) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Continuous Glucose Monitoring (CGM) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Continuous Glucose Monitoring (CGM) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Continuous Glucose Monitoring (CGM) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Continuous Glucose Monitoring (CGM) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Continuous Glucose Monitoring (CGM) market.
Market Segmentation:
Continuous Glucose Monitoring (CGM) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Transmitters
Sensors
Insulin Pumps
Segmentation by application
Hospitals
Homecare Settings
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Baxter
Abbott Laboratories
Medtronic
Animas
Novo Nordisk
Ypsomed
GlySens
Key Questions Addressed in this Report
What is the 10-year outlook for the global Continuous Glucose Monitoring (CGM) market?
What factors are driving Continuous Glucose Monitoring (CGM) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Continuous Glucose Monitoring (CGM) market opportunities vary by end market size?
How does Continuous Glucose Monitoring (CGM) break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Continuous Glucose Monitoring (CGM) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Continuous Glucose Monitoring (CGM) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Continuous Glucose Monitoring (CGM) by Country/Region, 2019, 2023 & 2030
2.2 Continuous Glucose Monitoring (CGM) Segment by Type
2.2.1 Transmitters
2.2.2 Sensors
2.2.3 Insulin Pumps
2.3 Continuous Glucose Monitoring (CGM) Sales by Type
2.3.1 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Type (2019-2024)
2.3.2 Global Continuous Glucose Monitoring (CGM) Revenue and Market Share by Type (2019-2024)
2.3.3 Global Continuous Glucose Monitoring (CGM) Sale Price by Type (2019-2024)
2.4 Continuous Glucose Monitoring (CGM) Segment by Application
2.4.1 Hospitals
2.4.2 Homecare Settings
2.4.3 Others
2.5 Continuous Glucose Monitoring (CGM) Sales by Application
2.5.1 Global Continuous Glucose Monitoring (CGM) Sale Market Share by Application (2019-2024)
2.5.2 Global Continuous Glucose Monitoring (CGM) Revenue and Market Share by Application (2019-2024)
2.5.3 Global Continuous Glucose Monitoring (CGM) Sale Price by Application (2019-2024)
3 Global Continuous Glucose Monitoring (CGM) by Company
3.1 Global Continuous Glucose Monitoring (CGM) Breakdown Data by Company
3.1.1 Global Continuous Glucose Monitoring (CGM) Annual Sales by Company (2019-2024)
3.1.2 Global Continuous Glucose Monitoring (CGM) Sales Market Share by Company (2019-2024)
3.2 Global Continuous Glucose Monitoring (CGM) Annual Revenue by Company (2019-2024)
3.2.1 Global Continuous Glucose Monitoring (CGM) Revenue by Company (2019-2024)
3.2.2 Global Continuous Glucose Monitoring (CGM) Revenue Market Share by Company (2019-2024)
3.3 Global Continuous Glucose Monitoring (CGM) Sale Price by Company
3.4 Key Manufacturers Continuous Glucose Monitoring (CGM) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Continuous Glucose Monitoring (CGM) Product Location Distribution
3.4.2 Players Continuous Glucose Monitoring (CGM) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Continuous Glucose Monitoring (CGM) by Geographic Region
4.1 World Historic Continuous Glucose Monitoring (CGM) Market Size by Geographic Region (2019-2024)
4.1.1 Global Continuous Glucose Monitoring (CGM) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Continuous Glucose Monitoring (CGM) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Continuous Glucose Monitoring (CGM) Market Size by Country/Region (2019-2024)
4.2.1 Global Continuous Glucose Monitoring (CGM) Annual Sales by Country/Region (2019-2024)
4.2.2 Global Continuous Glucose Monitoring (CGM) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Continuous Glucose Monitoring (CGM) Sales Growth
4.4 APAC Continuous Glucose Monitoring (CGM) Sales Growth
4.5 Europe Continuous Glucose Monitoring (CGM) Sales Growth
4.6 Middle East & Africa Continuous Glucose Monitoring (CGM) Sales Growth
5 Americas
5.1 Americas Continuous Glucose Monitoring (CGM) Sales by Country
5.1.1 Americas Continuous Glucose Monitoring (CGM) Sales by Country (2019-2024)
5.1.2 Americas Continuous Glucose Monitoring (CGM) Revenue by Country (2019-2024)
5.2 Americas Continuous Glucose Monitoring (CGM) Sales by Type
5.3 Americas Continuous Glucose Monitoring (CGM) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Continuous Glucose Monitoring (CGM) Sales by Region
6.1.1 APAC Continuous Glucose Monitoring (CGM) Sales by Region (2019-2024)
6.1.2 APAC Continuous Glucose Monitoring (CGM) Revenue by Region (2019-2024)
6.2 APAC Continuous Glucose Monitoring (CGM) Sales by Type
6.3 APAC Continuous Glucose Monitoring (CGM) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Continuous Glucose Monitoring (CGM) by Country
7.1.1 Europe Continuous Glucose Monitoring (CGM) Sales by Country (2019-2024)
7.1.2 Europe Continuous Glucose Monitoring (CGM) Revenue by Country (2019-2024)
7.2 Europe Continuous Glucose Monitoring (CGM) Sales by Type
7.3 Europe Continuous Glucose Monitoring (CGM) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Continuous Glucose Monitoring (CGM) by Country
8.1.1 Middle East & Africa Continuous Glucose Monitoring (CGM) Sales by Country (2019-2024)
8.1.2 Middle East & Africa Continuous Glucose Monitoring (CGM) Revenue by Country (2019-2024)
8.2 Middle East & Africa Continuous Glucose Monitoring (CGM) Sales by Type
8.3 Middle East & Africa Continuous Glucose Monitoring (CGM) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Continuous Glucose Monitoring (CGM)
10.3 Manufacturing Process Analysis of Continuous Glucose Monitoring (CGM)
10.4 Industry Chain Structure of Continuous Glucose Monitoring (CGM)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Continuous Glucose Monitoring (CGM) Distributors
11.3 Continuous Glucose Monitoring (CGM) Customer
12 World Forecast Review for Continuous Glucose Monitoring (CGM) by Geographic Region
12.1 Global Continuous Glucose Monitoring (CGM) Market Size Forecast by Region
12.1.1 Global Continuous Glucose Monitoring (CGM) Forecast by Region (2025-2030)
12.1.2 Global Continuous Glucose Monitoring (CGM) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Continuous Glucose Monitoring (CGM) Forecast by Type
12.7 Global Continuous Glucose Monitoring (CGM) Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
13.1.3 Pfizer Continuous Glucose Monitoring (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
13.2.3 Baxter Continuous Glucose Monitoring (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Information
13.3.2 Abbott Laboratories Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
13.3.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Abbott Laboratories Main Business Overview
13.3.5 Abbott Laboratories Latest Developments
13.4 Medtronic
13.4.1 Medtronic Company Information
13.4.2 Medtronic Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
13.4.3 Medtronic Continuous Glucose Monitoring (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Medtronic Main Business Overview
13.4.5 Medtronic Latest Developments
13.5 Animas
13.5.1 Animas Company Information
13.5.2 Animas Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
13.5.3 Animas Continuous Glucose Monitoring (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Animas Main Business Overview
13.5.5 Animas Latest Developments
13.6 Novo Nordisk
13.6.1 Novo Nordisk Company Information
13.6.2 Novo Nordisk Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
13.6.3 Novo Nordisk Continuous Glucose Monitoring (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Novo Nordisk Main Business Overview
13.6.5 Novo Nordisk Latest Developments
13.7 Ypsomed
13.7.1 Ypsomed Company Information
13.7.2 Ypsomed Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
13.7.3 Ypsomed Continuous Glucose Monitoring (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Ypsomed Main Business Overview
13.7.5 Ypsomed Latest Developments
13.8 GlySens
13.8.1 GlySens Company Information
13.8.2 GlySens Continuous Glucose Monitoring (CGM) Product Portfolios and Specifications
13.8.3 GlySens Continuous Glucose Monitoring (CGM) Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 GlySens Main Business Overview
13.8.5 GlySens Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂